Asclepius Ltd. was founded in 2006 in response to the ongoing growth of the clinical trials market in Russia. Asclepius Ltd. is an independent Contract Research Organization (CRO) dedicated to carrying out clinical trials in phases II-IV in Russia to the highest standards of GCP. With our experience of the Russian market we are confident that we can match the potential advantages of trialing your drug here with the most professional working practices. From our offices in London and Moscow we are ready to see through the design, setup and conduct of clinical trials, particularly large Phase II - IV international programmes involving hundreds of patients throughout Russia.